Compass Therapeutics Invites Investors to Upcoming Events
This September, Compass Therapeutics, Inc. (Nasdaq: CMPX), a notable name in the biopharmaceutical sector, has some exciting updates for investors. The company is recognized for its innovative strategies in oncology and is dedicated to developing proprietary antibody-based therapies to address various human diseases.
Upcoming Investor Events
Throughout the month, Compass Therapeutics will be participating in key investor events:
H.C. Wainwright 26th Annual Global Investment Conference
Date: September 9, 2024
Time: 11:00 AM ET
Cantor Global Healthcare Conference
Date: September 17, 2024
Time: 8:35 AM ET
Leveraging Technology for Greater Access
These events will showcase presentations highlighting the company's significant advancements in research and development. By registering for these conferences, investors will gain valuable insights into the company's future and learn about the innovative therapies currently in development.
Understanding Compass Therapeutics
Founded in 2014 and based in Boston, Massachusetts, Compass Therapeutics is at the cutting edge of biopharmaceutical innovation. The company focuses on the intricate relationship between angiogenesis—the process of forming new blood vessels—and the immune system in the context of tumor growth. Their goal is to advance a pipeline of novel product candidates that target essential biological mechanisms for effective anti-tumor responses.
Innovative Therapeutic Strategies
Compass Therapeutics is concentrating on several critical areas for therapeutic intervention, including agents that target angiogenesis, immune activators to enhance effector cell responses, and strategies to counteract tumor-induced immune suppression. This comprehensive approach positions Compass to deliver effective solutions in the ongoing battle against cancer.
Get in Touch with Compass Therapeutics
As Compass Therapeutics continues to lead in oncology innovation, the company values strong communication with its investors. For any questions regarding their operations or upcoming events, please reach out using the following contact information:
Investor Contact: ir@compasstherapeutics.com
Media Contact: Anna Gifford, Senior Communications Manager
Contact: 617-500-8099
Email: media@compasstherapeutics.com
Frequently Asked Questions
What is Compass Therapeutics focusing on in its research?
Compass Therapeutics is dedicated to developing antibody-based therapeutics aimed at treating various human diseases, with a particular emphasis on oncology.
When are the investor events taking place?
The upcoming investor events are scheduled for September 9 and September 17, 2024, offering opportunities for investors to connect with the company.
Where is Compass Therapeutics headquartered?
Compass Therapeutics is headquartered in Boston, Massachusetts, where it leads innovative biopharmaceutical research initiatives.
What therapeutic strategies is Compass implementing?
Compass employs strategies that focus on targeting angiogenesis, modulating immune responses, and disrupting mechanisms of tumor immune evasion to improve treatment outcomes.
How can I contact Compass Therapeutics for more information?
For inquiries, you can email ir@compasstherapeutics.com or reach out for media inquiries at media@compasstherapeutics.com.